News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biohit Acquires Rights To H. Pylori Quick Test – New Superior Test To Product Range During Q4



11/18/2013 9:31:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biohit Oyj acquires the rights to the UFT300 test, which is a rapid test for the diagnosis of Helicobacter pylori infection. Along with the agreement, the Italian developer, Advanced Biomedical Systems s.r.l. (ABS) gives Biohit the patent and distribution rights for the test. The purchase price is EUR 350,000 and the new H. pylori quick test will be incorporated into Biohit’s product range during the fourth quarter, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Biohit
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES